Johns Hopkins Diabetes Guide →Medications →Obesity

Lorcaserin

Stacy Elder Dalpoas, Pharm.D., BCPS, Clare Lee, M.D., MHS, Brian Pinto, Pharm.D
Lorcaserin is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Indicated for obese patients with an initial body mass index (BMI) ≥ 30 kg/m2, or overweight patients with a BMI ≥ 27 kg/m2 in the presence of at least one weight related comorbid condition (e.g., hypertension, dyslipidemia, cardiovascular disease, glucose intolerance, sleep apnea) for weight loss and maintenance of weight loss
  • Approved for use only in conjunction with a reduced-calorie diet and a program of regular exercise
  • Approved for adults, age 18 and older

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: September 6, 2017

Citation

TY - ELEC T1 - Lorcaserin ID - 547169 A1 - Dalpoas,Stacy,Pharm.D., BCPS AU - Lee,Clare,M.D., MHS AU - Pinto,Brian,Pharm.D Y1 - 2017/09/06/ PB - Johns Hopkins Diabetes Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_Diabetes_Guide/547169/all/Lorcaserin ER -